We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENIC icon
12526
Enel Chile
ENIC
$6.14B
$46K ﹤0.01%
25,685
-8,519
-25% -$18.2K
HYPD
12527
PUT
Hyperion DeFi Inc
HYPD
$56.3M
$46K ﹤0.01%
+145
New +$49.3K
IRON icon
12528
PUT
Disc Medicine
IRON
$3.17B
$46K ﹤0.01%
523
-57
-10% -$5.59K
JVA icon
12529
Coffee Holding Co
JVA
$19.8M
$46K ﹤0.01%
+10,614
New +$47.8K
OPTT icon
12530
PUT
Ocean Power Technologies
OPTT
$48.3M
$46K ﹤0.01%
30,800
-39,600
-56% -$77.1K
RAIL icon
12531
PUT
FreightCar America
RAIL
$237M
$46K ﹤0.01%
12,400
-19,600
-61% -$82.1K
RNAC icon
12532
PUT
Cartesian Therapeutics
RNAC
$302M
$46K ﹤0.01%
473
-70
-13% -$7.53K
YARW
12533
Yarrow Bioscience
YARW
$101M
$46K ﹤0.01%
50
+34
+213% +$36.5K
IVF
12534
INVO Fertility Inc
IVF
$2.58M
0
CONXW
12535
DELISTED
CONX Corp. Warrant
CONXW
$46K ﹤0.01%
53,318
NEX
12536
CALL
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$46K ﹤0.01%
13,000
-1,600
-11% -$6.7K
SGTX
12537
PUT
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$46K ﹤0.01%
1,269
-993
-44% -$56.5K
PRPB.WS
12538
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$46K ﹤0.01%
+33,814
New +$38.3K
ASRT
12539
PUT
DELISTED
Assertio
ASRT
$45K ﹤0.01%
1,380
-73
-5% -$1.5K
AVTX icon
12540
Avalo Therapeutics
AVTX
$1.08B
$45K ﹤0.01%
9
+2
+29% +$12K
BBAI.WS icon
12541
BigBear.ai Holdings Warrant
BBAI.WS
$28.9M
$45K ﹤0.01%
+55,431
New +$47.7K
FTEK icon
12542
CALL
Fuel Tech
FTEK
$45.6M
$45K ﹤0.01%
32,100
+600
+2% +$1.06K
GLMD icon
12543
CALL
Galmed Pharmaceuticals
GLMD
$4.49M
$45K ﹤0.01%
17
-3
-15% -$10.8K
TNXP icon
12544
Tonix Pharmaceuticals
TNXP
$233M
0
CRHC.WS
12545
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$45K ﹤0.01%
56,666
CO
12546
PUT
DELISTED
Global Cord Blood Corporation
CO
$45K ﹤0.01%
10,700
-32,300
-75% -$137K
ATHE
12547
Alterity Therapeutics
ATHE
$82.7M
$44K ﹤0.01%
+6,159
New +$66.8K
MITQ icon
12548
Moving iMage Technologies
MITQ
$5.77M
$44K ﹤0.01%
+21,092
New +$53.4K
TOON icon
12549
CALL
Kartoon Studios
TOON
$39.9M
$44K ﹤0.01%
4,210
-33,550
-89% -$439K
VANI icon
12550
CALL
Vivani Medical
VANI
$126M
$44K ﹤0.01%
8,933
-33,634
-79% -$246K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.